Catalyst Wire Dossier Catalyst Wire Dossier

daclatasvir dihydrochloride tablets

daclatasvir
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for daclatasvir dihydrochloride tablets, covering 2019-08-28 to 2019-08-28. Get the full timeline:

Most recent: Clinical Trial Update: SH229 Tablets Combined With Daclatasvir Dihydrochloride Tablets in Treatment Adult Patients With Chronic Hepatitis C [Phase 2, Phase 3]

See pricing